CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced the launch of a serum free media (SFM) designed specifically to culture mesenchymal stem cells (MSCs), or stem cells derived from bone marrow. STEMPRO® MSC SFM is a first of its kind product that overcomes many challenges in MSC culture. In concert, Invitrogen also launched two kits designed to allow the differentiation of MSCs to either adipocytes (fat cells) or osteocytes (bone cells).
